Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.73
05.01.23
€3.00
31.12.25
37.80%
06.01.23

Could be very worthwhile Investment >20% year
Novocure Ltd

Start price
Target price
Perf. (%)
€68.89
02.01.23
€30.00
31.12.25
71.43%
05.01.23

Could be very worthwhile Investment >20% year
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.50
04.01.23
€6.00
31.12.25
38.38%
04.01.23

Could be very worthwhile Investment >20% year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.01
03.01.22
€78.00
03.01.23
-2.98%
04.01.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.01
03.01.22
€78.00
03.01.23
-2.98%
04.01.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.70
30.09.22
€9.00
31.01.23
-12.08%
03.01.23

Could be very worthwhile Investment >20% year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
buy
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€11.38
29.12.21
€15.00
29.12.22
-0.92%
30.12.22

Could be worthwhile Investment >10% per year
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€10.70
29.12.21
-
29.12.22
5.37%
30.12.22

Risky Investment
Mainly gamblers invest here
Sustainability is not important
High valuation
buy
GSK plc

Start price
Target price
Perf. (%)
€19.38
29.12.21
-
29.12.22
-15.38%
30.12.22

buy
GSK plc

Start price
Target price
Perf. (%)
€19.38
29.12.21
-
29.12.22
-15.38%
30.12.22

buy
Opko Health Inc.

Start price
Target price
Perf. (%)
€4.65
28.12.21
-
28.12.22
-75.54%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€149.96
28.12.21
-
28.12.22
10.44%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€149.96
28.12.21
-
28.12.22
10.44%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
buy
arGEN X BV

Start price
Target price
Perf. (%)
€312.20
28.12.21
-
28.12.22
11.56%
29.12.22

buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.32
21.12.22
€11.00
31.03.24
29.21%
28.12.22

Could be very worthwhile Investment >20% year
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€19.00
27.12.21
-
27.12.22
8.55%
28.12.22

Could be worthwhile Investment >10% per year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.99
27.12.21
€42.00
27.12.22
-5.05%
28.12.22

Could be worthwhile Investment >10% per year
buy
Pluristem Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.41
27.12.21
€2.50
27.12.22
-31.19%
28.12.22

Could be worthwhile Investment >10% per year